These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 31606477)

  • 1. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
    Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
    Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
    Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
    Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
    Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
    Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
    Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.
    Aarsland TI; Leskauskaite I; Midttun Ø; Ulvik A; Ueland PM; Oltedal L; Erchinger VJ; Oedegaard KJ; Haavik J; Kessler U
    Brain Stimul; 2019; 12(5):1135-1142. PubMed ID: 31176607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.
    Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the kynurenine pathway in human glioma pathophysiology.
    Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
    PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis.
    Tömösi F; Kecskeméti G; Cseh EK; Szabó E; Rajda C; Kormány R; Szabó Z; Vécsei L; Janáky T
    J Pharm Biomed Anal; 2020 Jun; 185():113246. PubMed ID: 32182446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired kynurenine metabolism in patients with primary Sjögren's syndrome.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sak F; Humeyra Yerlikaya F; Yilmaz S; Abusoglu G; Kazim Korez M; Unlu A
    Clin Biochem; 2023 Apr; 114():1-10. PubMed ID: 36681140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
    Badawy AA
    Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
    Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine pathway in depression: A systematic review and meta-analysis.
    Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
    Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.